Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ) - Wikidata - awgldk - TriplyDB

Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ)

Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ)

http://www.wikidata.org/entity/Q37414538

about

Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration Two kinds of common prenatal screening tests for Down's syndrome: a systematic review and meta-analysis Optimization of plasma sample pretreatment for quantitative analysis using iTRAQ labeling and LC-MALDI-TOF/TOF Proteomic analysis of the marine diatom Thalassiosira pseudonana upon exposure to benzo(a)pyrene Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.PPINGUIN: Peptide Profiling Guided Identification of Proteins improves quantitation of iTRAQ ratios Placenta proteome analysis from Down syndrome pregnancies for biomarker discovery.Unveiling clusters of RNA transcript pairs associated with markers of Alzheimer's disease progression.Quantitative proteomic analysis of serum from pregnant women carrying a fetus with conotruncal heart defect using isobaric tags for relative and absolute quantitation (iTRAQ) labeling Protein analysis by shotgun/bottom-up proteomics Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met?2D DIGE analysis of maternal plasma for potential biomarkers of Down Syndrome Quantitative proteomics analysis by isobaric tags for relative and absolute quantitation identified Lumican as a potential marker for acute aortic dissection Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.Statistical considerations of optimal study design for human plasma proteomics and biomarker discovery Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia Bioinformatics characterization of differential proteins in serum of mothers carrying Down syndrome fetuses: combining bioinformatics and ELISA.Biomarker development for non-invasive prenatal diagnosis of fetal aneuploidies: predictive reliability and potential clinical application.iTRAQ-based proteomic analysis of hepatic tissues from patients with hepatitis B virus-induced acute-on-chronic liver failure.Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal.Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects Impact of peptide modifications on the isobaric tags for relative and absolute quantitation method accuracy.Identification of potential protein biomarkers for early detection of pregnancy in cow urine using 2D DIGE and label free quantitation.ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma.Non invasive prenatal diagnosis of aneuploidy: next generation sequencing or fetal DNA enrichment?Serum proteomics analysis and comparisons using iTRAQ in the progression of hepatitis B.Integrated microRNA and protein expression analysis reveals novel microRNA regulation of targets in fetal down syndrome.Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics.Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.Profiling for novel proteomics biomarkers in neurodevelopmental disorders.Bioinformatics approaches in the discovery and understanding of reproduction-related biomarkers.To label or not to label: applications of quantitative proteomics in neuroscience research.Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.Prenatal diagnosis of fetal aneuploidies: post-genomic developments.Revisiting biomarker discovery by plasma proteomics.Serum amyloid-p (SAP), a potential biomarker for Down syndrome fetuses prevention in maternal plasma.

P2860

Q27026686-B7C6CF10-391E-4185-9797-F2269D72AB89 Q28077443-DB0EFBE8-A8C4-4F84-8FF8-B99CB588D45B Q28540277-2E7BE6A0-283A-4335-AC90-9CC9D04AC56E Q28741135-F2BE5274-8B7D-492C-8401-6325D4EF667C Q30524877-5ED7DE51-53A2-4D7F-B6BF-CEB392C3C0D7 Q33886427-A9D2EA25-1700-4F47-9C8D-C8BBB941C670 Q33891197-ACB5C308-6980-46E1-9372-DF897BBD7EC2 Q34160509-58C4BCFE-A99F-43D3-B1FD-4A2E8F34EEE7 Q34331621-C929F377-630B-42FD-BC15-18DD3BFA185C Q34429308-BFB8DD4D-3366-4913-8BCF-1AAC42130761 Q34505748-E41EA07C-EC09-4AF5-B54B-1625776C56D1 Q34600986-B5DC857F-8374-4A34-9C3C-FEB9B0CE3702 Q34921561-F3DE8179-5FF5-4EBF-A415-BB42B94CC5C3 Q35298620-36615E6B-7A18-4C4C-8302-821C3083457F Q35649340-3B0D7180-46EC-4FA2-98D3-2F6AF83C5FD1 Q35773708-AEC0EE8D-90EA-4EEF-BFFB-D7EDCD47F846 Q35873957-7081C7E7-7412-4D95-85E3-B3DD00C91DDA Q35909762-20C4A3AC-D191-49BA-9A21-42E87CAFE1D2 Q35990381-F7B74937-714A-4F51-B976-690D843AC69A Q36117903-C74FECCE-F835-4DB9-8A3F-16EA64442934 Q36334771-FF8104DC-B289-4F96-BFF1-2F0829933C47 Q36357099-4C7DFFAC-30C7-4E0B-ABC7-F6A734D76A43 Q36435662-C5E17592-830F-4C14-ACE5-BD7466CAE75D Q36448934-AA67D189-FB2B-409C-A65C-5E918788879F Q37029356-CC46AF32-1FC5-450F-A829-E12E7C90A46B Q37097132-05A02459-2B88-4016-9422-77A77D9716FF Q37165264-B61FADBF-FE26-48FE-8140-A1BD8395CBB2 Q37181536-1087216D-415F-4402-951E-95B2B203E5EE Q37288988-231654C0-0F2E-4C29-9548-B327A5E33C49 Q37403230-0C7793DA-2778-4C3E-B950-0F4FB6F22D1C Q37504001-072F3B93-228A-43AC-965F-ED3B0C905282 Q37662773-3A014ABA-E24B-4495-83A7-67B2169ECB27 Q37844157-A4CB3E9C-6375-4566-9C48-F4964B1889FA Q37866308-1779CE3A-3F62-4741-ACCB-CA7157425247 Q37976002-E13E5CFC-6C93-427C-A179-9DAF06A1CB31 Q38497910-14D66F5D-E961-42F0-94B0-0DCC4DF2319B Q39433562-DF882A69-5678-455F-8941-BAFEA232702B Q39850180-6D245C7A-1B71-43EA-A2B0-DD68029C5383 Q41676452-4928380D-9E74-4257-A525-AC921EA310A1 Q46041480-D2F6E795-0B9B-4B11-8167-5930E8F7949C

P2860

Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ)

http://www.wikidata.org/entity/Q37414538

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Quantitative proteomics analys ...... obaric tagging reagent (iTRAQ)

@en

Quantitative proteomics analys ...... using isobaric tagging reagent

@nl

type

label

Quantitative proteomics analys ...... obaric tagging reagent (iTRAQ)

@en

Quantitative proteomics analys ...... using isobaric tagging reagent

@nl

prefLabel

Quantitative proteomics analys ...... obaric tagging reagent (iTRAQ)

@en

Quantitative proteomics analys ...... using isobaric tagging reagent

@nl

P1433

Q37414538-2AE22105-2814-4982-A8DB-E3D49AF9EBF2

P1476

Q37414538-443FA991-DA84-48B3-9153-D4964CF12C78

P2093

Q37414538-07D146EF-86AA-4121-B2E2-1F8714A4F57F

Q37414538-1411FD1B-03C7-4EEE-8846-81C230DD39C2

Q37414538-1481967F-B8CF-45B1-8DFE-BD8D2E913C4B

Q37414538-420C0906-9458-44C0-ACB4-A5CC6045589F

Q37414538-BF4337B2-B23E-40E3-A2C2-6AF30FB6DFE7

Q37414538-DB70716A-1CE0-4783-88D1-534D7BF6AC6C

Q37414538-DD52C705-835A-422D-9E48-BA6937B61BAB

P2860

Q37414538-0AB68FB3-E500-42B7-9811-B4A0C78EED75

Q37414538-110A16FF-FB4D-4094-A885-B30BAFFB91A1

Q37414538-17816B3B-60F7-4E09-A816-15090CA00647

Q37414538-2B760B69-3266-474A-927D-6DCC95804079

Q37414538-3498273A-B8D3-4462-811A-18ADD78F1CD4

Q37414538-3616DFA2-2532-40F5-86AF-DAFA854DC449

Q37414538-3CD79833-8E3E-449C-8B62-3D4B294836F4

Q37414538-4239105F-C3B8-4C7A-84D9-99FCF395626A

Q37414538-4853C1C7-09C7-4F7B-8BA9-BD5D2188A934

Q37414538-4EB12AD4-9D50-45A3-9173-668565D5AE09

P304

Q37414538-6320424F-1725-4B63-8ACA-764FBFE37D5F

P31

Q37414538-EE47845D-B9AB-40DC-AA62-CCA23E7BEB1A

P356

Q37414538-5C6E3590-9335-491F-96E9-FAABF1574127

P478

Q37414538-514B4EA9-CF12-4731-A58A-0AE67A1A9DBA

P577

Q37414538-E5A9C6C8-437A-4C35-BCD7-62DEFE518C4F

P5875

Q37414538-80EC24B5-753D-4577-832F-C6A3A46A4683

P698

Q37414538-B5CC88FF-1A0C-4BCE-A536-77F4E55DDDA0

P932

Q37414538-94692F28-9CBD-450D-ABFA-2DB1F563E0F0

P356

P1433

Journal of Biomedicine and Biotechnology

P1476

Quantitative proteomics analys ...... obaric tagging reagent (iTRAQ)

@en

P2093

Mahesh Choolani

http://www.w3.org/2001/XMLSchema#string

Olav Lapaire

http://www.w3.org/2001/XMLSchema#string

Paul Jenö

http://www.w3.org/2001/XMLSchema#string

Sevgi Tercanli

http://www.w3.org/2001/XMLSchema#string

Sinuhe Hahn

http://www.w3.org/2001/XMLSchema#string

Suzette Moes

http://www.w3.org/2001/XMLSchema#string

Varaprasad Kolla

http://www.w3.org/2001/XMLSchema#string

P2860

PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways

The human plasma proteome: history, character, and diagnostic prospects

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

Proteome analysis of maternal serum samples for trisomy 21 pregnancies using ProteinChip arrays and bioinformatics.

Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Protein Equalizer Technology : the quest for a "democratic proteome".

The normal human amniotic fluid supernatant proteome.

Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers.

Pregnancy loss rates after midtrimester amniocentesis.

P304

952047

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/952047

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38078762

http://www.w3.org/2001/XMLSchema#string

P698

19902006

http://www.w3.org/2001/XMLSchema#string

P932

2774473

http://www.w3.org/2001/XMLSchema#string